PRL3-zumab, a first-in-class humanized antibody for cancer therapy. (Q37277211)
Jump to navigation
Jump to search
scientific article published on 16 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | PRL3-zumab, a first-in-class humanized antibody for cancer therapy. |
scientific article published on 16 June 2016 |
Statements
PRL3-zumab, a first-in-class humanized antibody for cancer therapy (English)
Min Thura
Abdul Qader Omer Al-Aidaroos
Wei Peng Yong
Koji Kono
Abhishek Gupta
You Bin Lin
Kousaku Mimura
Jean Paul Thiery
Boon Cher Goh
Patrick Tan
Ross Soo
Cheng William Hong
Lingzhi Wang
Suling Joyce Lin
Elya Chen
Sun Young Rha
Hyun Cheol Chung
Jie Li
Sayantani Nandi
Hiu Fung Yuen
Yeoh Khay Guan
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference